Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Uknowiton Feb 17, 2021 9:29pm
168 Views
Post# 32592391

RE:A bit surprised we didn't couple the raise with a NAS

RE:A bit surprised we didn't couple the raise with a NAS

There was no room left in the chart for news on the Nasdaq listing.  This needs a correction and maybe we'll see that after this news? Or we'll see a slight drop and consolidation to reduce the RSI and straighten out other indicators. Like I said, this news couldn't have come at a better time!


Goaweigh wrote: co-listing but I guess if a broker calls and is waving wads of dough in front of your face and tells you it's going to disappear in 10, 9 ,8 ....you better grab it fast and so I expect that's exactly what happened. Then there's the idea that we are in the sweet spot for a partnering with the majors which has been borne out by the Nuance deal so why would we do a raise now but this raise isn't a negative leading indicator that a deal may not be forthcoming, again when a broker comes calling with a fat stack ( my kids used that one for awhile ) you don't turn them away regardless of what you might believe is just over the horizon. Shite happens fast in business and bad shite even faster so only idiots turn down cash.
Any day a broker is prepared to do a big deal with a fast close, is a good day.
How soon we forget bear markets.

Someone said they're going to be shakin the tree tomorrow, I love that expression. I've been buying spec darlings for 35 years and some ahole is always shakin the tree and I'm always hanging on for dear life.
So if you see a guy with abnormally long arms and balding, sortof like an Orangutan, it's probably me.
I'll be hanging on for awhile yet I think.  



 

<< Previous
Bullboard Posts
Next >>